245 related articles for article (PubMed ID: 31653413)
1. What Can We Learn About Drug Safety and Other Effects in the Era of Electronic Health Records and Big Data That We Would Not Be Able to Learn From Classic Epidemiology?
Zarrinpar A; David Cheng TY; Huo Z
J Surg Res; 2020 Feb; 246():599-604. PubMed ID: 31653413
[TBL] [Abstract][Full Text] [Related]
2. From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources.
Trifirò G; Sultana J; Bate A
Drug Saf; 2018 Feb; 41(2):143-149. PubMed ID: 28840504
[TBL] [Abstract][Full Text] [Related]
3. Restricted Versus Unrestricted Search Space: Experience from Mining a Large Japanese Database.
Nienhoff H; Huebner U; Frey A; Przysucha M; Kimura M
Stud Health Technol Inform; 2015; 216():1072. PubMed ID: 26262371
[TBL] [Abstract][Full Text] [Related]
4. Natural Language Processing and Its Implications for the Future of Medication Safety: A Narrative Review of Recent Advances and Challenges.
Wong A; Plasek JM; Montecalvo SP; Zhou L
Pharmacotherapy; 2018 Aug; 38(8):822-841. PubMed ID: 29884988
[TBL] [Abstract][Full Text] [Related]
5. Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs.
Lin KJ; Schneeweiss S
Clin Pharmacol Ther; 2016 Aug; 100(2):147-59. PubMed ID: 26916672
[TBL] [Abstract][Full Text] [Related]
6. Big Data in Cancer Research: Real-World Resources for Precision Oncology to Improve Cancer Care Delivery.
Tsai CJ; Riaz N; Gomez SL
Semin Radiat Oncol; 2019 Oct; 29(4):306-310. PubMed ID: 31472730
[TBL] [Abstract][Full Text] [Related]
7. [Benefits of large healthcare databases for drug risk research].
Garbe E; Pigeot I
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Aug; 58(8):829-837. PubMed ID: 26092163
[TBL] [Abstract][Full Text] [Related]
8. Electronic Health Record-Enabled Big-Data Approaches to Nephrotoxin-Associated Acute Kidney Injury Risk Prediction.
Sutherland SM
Pharmacotherapy; 2018 Aug; 38(8):804-812. PubMed ID: 29885015
[TBL] [Abstract][Full Text] [Related]
9. Application and optimisation of the Comparison on Extreme Laboratory Tests (CERT) algorithm for detection of adverse drug reactions: Transferability across national boundaries.
Tham MY; Ye Q; Ang PS; Fan LY; Yoon D; Park RW; Ling ZJ; Yip JW; Tai BC; Evans SJ; Sung C
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):87-94. PubMed ID: 29108136
[TBL] [Abstract][Full Text] [Related]
10. Using predictive analytics and big data to optimize pharmaceutical outcomes.
Hernandez I; Zhang Y
Am J Health Syst Pharm; 2017 Sep; 74(18):1494-1500. PubMed ID: 28887351
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of Prioritizing Drug-Drug-Event Associations Found in Electronic Health Records.
Banda JM; Callahan A; Winnenburg R; Strasberg HR; Cami A; Reis BY; Vilar S; Hripcsak G; Dumontier M; Shah NH
Drug Saf; 2016 Jan; 39(1):45-57. PubMed ID: 26446143
[TBL] [Abstract][Full Text] [Related]
12. Big Data in the Assessment of Pediatric Medication Safety.
McMahon AW; Cooper WO; Brown JS; Carleton B; Doshi-Velez F; Kohane I; Goldman JL; Hoffman MA; Kamaleswaran R; Sakiyama M; Sekine S; Sturkenboom MCJM; Turner MA; Califf RM
Pediatrics; 2020 Feb; 145(2):. PubMed ID: 31937606
[TBL] [Abstract][Full Text] [Related]
13. Big Data Mining and Adverse Event Pattern Analysis in Clinical Drug Trials.
Federer C; Yoo M; Tan AC
Assay Drug Dev Technol; 2016 Dec; 14(10):557-566. PubMed ID: 27631620
[TBL] [Abstract][Full Text] [Related]
14. The role of electronic healthcare record databases in paediatric drug safety surveillance: a retrospective cohort study.
de Bie S; Coloma PM; Ferrajolo C; Verhamme KM; Trifirò G; Schuemie MJ; Straus SM; Gini R; Herings R; Mazzaglia G; Picelli G; Ghirardi A; Pedersen L; Stricker BH; van der Lei J; Sturkenboom MC;
Br J Clin Pharmacol; 2015 Aug; 80(2):304-14. PubMed ID: 25683723
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Practice Research Datalink for drug safety in pregnancy research: an overview.
Charlton R; Snowball J; Sammon C; de Vries C
Therapie; 2014; 69(1):83-9. PubMed ID: 24698192
[TBL] [Abstract][Full Text] [Related]
16. Text Mining for Precision Medicine: Bringing Structure to EHRs and Biomedical Literature to Understand Genes and Health.
Simmons M; Singhal A; Lu Z
Adv Exp Med Biol; 2016; 939():139-166. PubMed ID: 27807747
[TBL] [Abstract][Full Text] [Related]
17. A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.
Xu Y; Zhou X; Suehs BT; Hartzema AG; Kahn MG; Moride Y; Sauer BC; Liu Q; Moll K; Pasquale MK; Nair VP; Bate A
Drug Saf; 2015 Aug; 38(8):749-65. PubMed ID: 26055920
[TBL] [Abstract][Full Text] [Related]
18. Hope, hype and harms of Big Data.
Scott IA
Intern Med J; 2019 Jan; 49(1):126-129. PubMed ID: 30680901
[TBL] [Abstract][Full Text] [Related]
19. Common Models, Different Approaches.
Gagne JJ
Drug Saf; 2015 Aug; 38(8):683-6. PubMed ID: 26088718
[No Abstract] [Full Text] [Related]
20. Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection.
Pacurariu AC; Straus SM; Trifirò G; Schuemie MJ; Gini R; Herings R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Arlett P; van der Lei J; Sturkenboom MC; Coloma PM
Drug Saf; 2015 Dec; 38(12):1201-10. PubMed ID: 26370104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
